BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27189701)

  • 1. RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    Liu H; Ding L; Shen Y; Zhong F; Wang Q; Xu X
    Int J Biol Macromol; 2016 Oct; 91():115-22. PubMed ID: 27189701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.
    Shen Y; Sun Y; Zhang L; Liu H
    Tumour Biol; 2017 Jun; 39(6):1010428317703941. PubMed ID: 28653881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C
    Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Capon in multiple myeloma.
    Shen Y; Liu H; Gu S; Wei Z; Liu H
    Tumour Biol; 2017 Jul; 39(7):1010428317713674. PubMed ID: 28671047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).
    Xu X; Wang Q; He Y; Ding L; Zhong F; Ou Y; Shen Y; Liu H; He S
    Ann Hematol; 2017 May; 96(5):847-858. PubMed ID: 28238095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism.
    Kobune M; Chiba H; Kato J; Kato K; Nakamura K; Kawano Y; Takada K; Takimoto R; Takayama T; Hamada H; Niitsu Y
    Mol Cancer Ther; 2007 Jun; 6(6):1774-84. PubMed ID: 17575106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells.
    Xu X; He Y; Miao X; Wu Y; Han J; Wang Q; Liu J; Zhong F; Ou Y; Wang Y; He S
    Leuk Res; 2016 Aug; 47():54-62. PubMed ID: 27258734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical role of RBQ3 in gliomas.
    Zhao C; Chen W; Dai S; Zhang X; Ban N; Fan S; Bao Z; Sun J; Shen C; Xia X; Zhang L; Ren J
    J Neurol Sci; 2015 Dec; 359(1-2):177-84. PubMed ID: 26671109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RACK1 on cell proliferation, adhesion, and bortezomib-induced apoptosis in multiple myeloma.
    Zhang L; Xu Y; Wang L; Liu H
    Int J Biol Macromol; 2019 Jan; 121():1077-1085. PubMed ID: 30315883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
    Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
    Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
    Ding L; Shen Y; Ni J; Ou Y; Ou Y; Liu H
    Tumour Biol; 2017 Mar; 39(3):1010428317694298. PubMed ID: 28351297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.
    Azab F; Vali S; Abraham J; Potter N; Muz B; de la Puente P; Fiala M; Paasch J; Sultana Z; Tyagi A; Abbasi T; Vij R; Azab AK
    Br J Haematol; 2014 Apr; 165(1):89-101. PubMed ID: 24405121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
    Nefedova Y; Landowski TH; Dalton WS
    Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
    Ding T; Hao J
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.
    Tang J; Ji L; Wang Y; Huang Y; Yin H; He Y; Liu J; Miao X; Wu Y; Xu X; He S; Cheng C
    Int J Hematol; 2015 Jul; 102(1):25-34. PubMed ID: 25804841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma.
    Furukawa Y; Kikuchi J
    Int J Hematol; 2016 Sep; 104(3):281-92. PubMed ID: 27411688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.